BROOKSIDE GROUP PRACTICE — All Prescriptions & Medications — Page 13
Practice Code: K81047 | READING, RG6 5HZ
Showing results 601-650 of 702
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Ciprofloxacin | 15 | 80 | £72 | +88.8% ▲ |
| Amorolfine hydrochloride | 15 | 95 | £126 | -35.0% ▼ |
| Alkyl sulphate | 15 | 3,540 | £92 | +62.3% ▲ |
| 15 | 200 | £445 | -4.4% ▼ | |
| 15 | 44 | £3.6K | -58.0% ▼ | |
| 15 | 870 | £3.1K | -38.4% ▼ | |
| Co-amilofruse (Amiloride hydrochloride/frusemide) | 14 | 784 | £102 | -59.8% ▼ |
| Rimegepant | 14 | 138 | £1.8K | +42.7% ▲ |
| Perampanel | 14 | 4,760 | £1.7K | -35.4% ▼ |
| Alogliptin/metformin | 14 | 1,568 | £708 | -66.4% ▼ |
| Oral rehydration salts | 14 | 656 | £271 | -51.5% ▼ |
| Powder 1.5 kcal/ml smoothie plant based (0913011) | 14 | 420 | £400 | +29.8% ▲ |
| RtS 2 - 2.4 kcal/ml m/sk lower volume with fibre (0913011) | 14 | 120.0K | £2.6K | +12.9% ▲ |
| RtS 2.4 kcal/ml m/sk lower volume, higher protein (0913011) | 14 | 57.0K | £1.2K | -80.0% ▼ |
| Ready to serve 1.5 kcal/ml milkshake (0913021) | 14 | 164.2K | £4.0K | +31.2% ▲ |
| Tube feed 1 kcal/ml with fibre, higher protein (0914011) | 14 | 410.0K | £7.0K | +54.3% ▲ |
| Tube feed 1.2 kcal/ml higher protein (0914011) | 14 | 323.0K | £4.8K | +84.7% ▲ |
| Fluorometholone | 14 | 80 | £26 | -2.8% ▼ |
| Pilocarpine hydrochloride | 14 | 2,072 | £965 | +30.3% ▲ |
| 14 | 295 | £317 | -62.3% ▼ | |
| 14 | 640 | £159 | -4.9% ▼ | |
| 14 | 1,350 | £194 | -21.2% ▼ | |
| 14 | 18 | £930 | +236.6% ▲ | |
| 14 | 360 | £1.8K | +48.3% ▲ | |
| Captopril | 13 | 1,064 | £330 | -10.2% ▼ |
| Eprosartan | 13 | 686 | £333 | -35.6% ▼ |
| Dapagliflozin/metformin | 13 | 728 | £452 | -70.4% ▼ |
| Canagliflozin | 13 | 752 | £934 | -90.9% ▼ |
| Exenatide | 13 | 52 | £954 | -25.9% ▼ |
| Ascorbic acid | 13 | 1,240 | £1.6K | -36.7% ▼ |
| Pdr 3.8 - 4.9 kcal/g energy (carbohyd) fortifier (0913142) | 13 | 8,200 | £116 | +63.2% ▲ |
| 13 | 195.0K | £3.8K | +43.4% ▲ | |
| Celecoxib | 13 | 870 | £40 | -80.3% ▼ |
| Urea hydrogen peroxide | 13 | 112 | £46 | +159.5% ▲ |
| 13 | 125 | £68 | -87.3% ▼ | |
| 13 | 480 | £391 | -53.0% ▼ | |
| 13 | 1,400 | £68 | -48.3% ▼ | |
| 13 | 780 | £2.6K | -9.1% ▼ | |
| 13 | 390 | £1.3K | +13.5% ▲ | |
| 13 | 610 | £300 | -15.6% ▼ | |
| 13 | 3,485 | £487 | -1.5% vs avg | |
| 13 | 1,110 | £1.7K | +48.3% ▲ | |
| Zinc oxide | 12 | 325 | £38 | -42.0% ▼ |
| Minoxidil | 12 | 672 | £133 | +7.7% ▲ |
| Trimetazidine hydrochloride | 12 | 1,260 | £3.3K | +47.7% ▲ |
| Levomepromazine hydrochloride | 12 | 115 | £220 | -47.9% ▼ |
| Tapentadol | 12 | 616 | £274 | -70.9% ▼ |
| Riluzole | 12 | 2,208 | £5.8K | +15.6% ▲ |
| Bupropion hydrochloride | 12 | 1,080 | £714 | +11.0% ▲ |
| Mebendazole | 12 | 343 | £19 | +4.8% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.